Brazilian Versamune Covid vaccine may be included in National Immunization Plan this year
The vaccine is currently in its trial phase authorized by the Brazilian Health Regulatory Agency (ANVISA).
July 19, 2021
The vaccine is currently in its trial phase authorized by the Brazilian Health Regulatory Agency (ANVISA).
July 19, 2021
Health Minister Marcelo Queiroga on Wednesday, July 14, assured that the number of doses contracted by the National Immunization Plan...
July 15, 2021
The Brazilian Health Regulatory Agency (ANVISA) on Wednesday announced that it granted authorization for clinical trials in Brazil of two...
July 14, 2021
Brazil's health regulator has requested vaccine manufacturers Janssen/Johnson & Johnson and AstraZeneca/Fiocruz to include in their Covid-19 immunizers' package inserts...
July 13, 2021
The Brazilian Health Regulatory Agency (ANVISA) has authorized the production of vaccines against Covid-19 in a Hospira company plant in...
July 9, 2021
The concurrent phase 1 and 2 trial is the 8th approved in Brazil; 150 volunteers will be selected in Bahia,...
July 7, 2021
The Ministry of Health's logistics director had demanded US$1 in return for each vaccine dose purchased by the South American...
June 30, 2021
Chinese Sinovac Biotech's CoronaVac, the Covid-19 vaccine filled in Brazil by the Butantan Institute, is safe and induces immune response...
June 29, 2021
he Brazilian Health Regulator Agency (ANVISA) has sent State Secretariats an alert about the potential adulteration of CoronaVac vaccines, used...
June 29, 2021